Sullivan Named to Chair BECON

Dr. Daniel C. Sullivan has been named the new chair of the Bioengineering Consortium (BECON), effective Jan. 21. He is associate director of the Cancer Imaging Program, NCI. He has been active in BECON since the consortium was established in 1997 and was the NIH chair for the BECON Symposium on "Catalyzing Team Science" in June 2003. He succeeds Dr. Jeff Schloss of NHGRI who chaired the consortium since October 2001. Under Schloss' leadership, several trans-NIH biomedical research opportunities were initiated and implemented, two major BECON symposia were conducted, and the consortium continued to develop as an effective entity that coordinates multidisciplinary and team research and inter-agency activities related to bioengineering. BECON is administered by the National Institute of Biomedical Imaging and Bioengineering.

DeClue Joins CSR

Dr. Jeffrey E. DeClue recently joined the Center for Scientific Review as a scientific review administrator in the musculoskeletal, oral, and skin sciences integrated review group. He received his Ph.D. from the University of California, Berkeley, for studies on viral oncogenes encoding protein-tyrosine kinases. He joined the NCI intramural program as a postdoctoral fellow in 1989, and continued there through July 2003 as a principal investigator in the Center for Cancer Research. His initial studies at NCI focused on the function and regulation of the Ras gene products in growth and oncogenesis. These studies led to further work involving the role of Ras, the neurofibromatosis type 1 gene product, and the epidermal growth factor receptor in the benign and malignant tumors that characterize this disease.